Get started
Author

Amna Bint I Munir

Disparities in Place of Death Among Malnourished Individuals in the United States
2024 · Maithili Chamanoor, Riyam Kaur Juneja, et al. · Cureus · 6
PDF
Genomic characterization of conventional, dedifferentiated, and mesenchymal chondrosarcoma: A 550-patient multicenter analysis.
2026 · Luyuan Li, Genevieve Bertolet, et al. · Journal of Clinical Oncology · 2
Vaccine Induced Immune Thrombotic Thrombocytopenia After Sinopharm Vaccination: A Systematic Review of Case Reports
2025 · Shafi Rehman, Mahnoor Sukaina, et al. · Clinical Case Reports · 1
PDF
Pharmacogenomics & Personalized Medication Management in Geriatric Psychiatry: A Systematic Review
2024 · Sujan Poudel, Elona Greca, et al. · American Journal of Geriatric Psychiatry · 1
Impact of Early Bloodstream Infections on Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
2026 · Moazzam Shahzad, Muhammad Kashif Amin, et al. · Transplantation and Cellular Therapy
PDF
Efficacy-toxicity paradox of perioperative immune checkpoint inhibitors: An ESMO-MCBS v2.0 quality analysis of FDA approvals.
2026 · Haritha Gandicheruvu, Abhenil Mittal, et al. · JCO Oncology Practice
POSTER: CLL-1623: Risk of Therapy-Related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Treated With BTK Inhibitors: A Retrospective Multicenter Analysis Using the TriNetX Database
2026 · Amna Bint I Munir, Juhi Chovatiya, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-1686: Temporal Trends in Mortality Associated With Non-Hodgkin Lymphoma and Ischemic Heart Disease in the United States: A CDC WONDER Joinpoint Analysis (1999–2020)
2026 · Neha Singh, Amna Bint I Munir, et al. · Clinical Lymphoma Myeloma & Leukemia
HL-1605: When Sepsis Is Not Sepsis: Classical Hodgkin Lymphoma Presenting as Secondary Hemophagocytic Lymphohistiocytosis
2026 · Sapna Kumari, Ashish Nepal, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1417: Real-World Comparative Survival and Hospitalization Outcomes After CAR-T Relapse in Relapsed/Refractory Multiple Myeloma: Bispecific Antibodies Versus Conventional Chemotherapy
2026 · Sumbal Aziz, Woo Joo Lee, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-1652: Impact of Diabetes Mellitus on Outcomes and Toxicity in Patients With Diffuse Large B-Cell Lymphoma Treated With Bispecific Antibodies: A Real-World Propensity Score-Matched Analysis
2026 · Juhi Ardeshna-Chovatiya, Wei Ju Lin, et al. · Clinical Lymphoma Myeloma & Leukemia
CLL-1623: Risk of Therapy-Related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Treated With BTK Inhibitors: A Retrospective Multicenter Analysis Using the TriNetX Database
2026 · Amna Bint I. Munir, Juhi Chovatiya, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1669: Population-Level Trends in Sepsis-Related Mortality Among Patients With Multiple Myeloma: Insights From CDC WONDER
2026 · Amna Bint I Munir, Neha Singh, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MPN-1675: Luspatercept for Anemia in Myelofibrosis: A Systematic Evidence Synthesis and Random-Effects Meta-Analysis
2026 · Arafat Shabbir, Anas Al-Sadi, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1644: Impact of Diabetes Mellitus on Outcomes in Multiple Myeloma Patients Receiving Bispecific Antibodies: A Real-World Analysis
2026 · Juhi Ardeshna-Chovatiya, Wei Ju Lin, et al. · Clinical Lymphoma Myeloma & Leukemia
MPN-1675: Luspatercept for Anemia in Myelofibrosis: A Systematic Evidence Synthesis and Random-Effects Meta-Analysis
2026 · Arafat Shabbir, Anas Al-Sadi, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-1686: Temporal Trends in Mortality Associated With Non-Hodgkin Lymphoma and Ischemic Heart Disease in the United States: ACDCWONDER Joinpoint Analysis (1999–2020)
2026 · Neha Singh, Amna Bint I Munir, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1644: Impact of Diabetes Mellitus on Outcomes in Multiple Myeloma Patients Receiving Bispecific Antibodies: A Real-World Analysis
2026 · Juhi Ardeshna-Chovatiya, Wei Ju Lin, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-1652: Impact of Diabetes Mellitus on Outcomes and Toxicity in Patients With Diffuse Large B-Cell Lymphoma Treated With Bispecific Antibodies: A Real-World Propensity Score-Matched Analysis
2026 · Juhi Ardeshna-Chovatiya, Wei Ju Lin, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1669: Population-Level Trends in Sepsis-Related Mortality Among Patients With Multiple Myeloma: Insights From CDC WONDER
2026 · Amna Bint IMunir, Neha Singh, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1417: Real-World Comparative Survival and Hospitalization Outcomes After CAR-T Relapse in Relapsed/Refractory Multiple Myeloma: Bispecific Antibodies Versus Conventional Chemotherapy
2026 · Sumbal Aziz, Woo Joo Lee, et al. · Clinical Lymphoma Myeloma & Leukemia
Comparison of chemotherapy–immunotherapy and chemoradiation in esophageal cancer: A TriNetX real-world evidence study.
2026 · Luyuan Li, Amna Bint I Munir, et al. · Journal of Clinical Oncology
Efficacy of Lu-PSMA–based treatment strategies in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
2026 · Sapna Kumari, Amna Bint I Munir, et al. · Journal of Clinical Oncology
PDF
Comparative toxicity profile of chimeric antigen receptor T-cell therapy versus bispecific T-cell engagers in multiple myeloma and B-cell lymphomas: A propensity-matched real-world analysis.
2026 · Amna Bint I Munir, Sapna Kumari, et al. · Journal of Clinical Oncology
Real-world survival outcomes of patients with cholangiocarcinoma receiving chemotherapy versus chemo-immunotherapy: A TriNetX database analysis.
2026 · Sapna Kumari, Amna Bint I Munir, et al. · Journal of Clinical Oncology
Works count: 41
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type